These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33012643)

  • 1. Changing understanding, perceptions, pain relief of and preference for generic medicines with patient education: An experimental intervention study.
    Kleinstäuber M; Colgan S; Petrie KJ
    Res Social Adm Pharm; 2021 Jul; 17(7):1288-1299. PubMed ID: 33012643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trust in the approval process of medicines mediates the effect of an educational intervention on the pain relief induced by a generic analgesic.
    Kleinstäuber M; Colgan S; Petrie KJ
    Res Social Adm Pharm; 2023 Aug; 19(8):1178-1183. PubMed ID: 37142475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing perceptions and efficacy of generic medicines: An intervention study.
    Colgan SL; Faasse K; Pereira JA; Grey A; Petrie KJ
    Health Psychol; 2016 Nov; 35(11):1246-1253. PubMed ID: 27505191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between senior medical students' and pharmacy pre-registrants' knowledge and perceptions of generic medicines.
    Hassali MA; Kong DC; Stewart K
    Med Educ; 2007 Jul; 41(7):703-10. PubMed ID: 17614892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.
    van der Meersch A; Dechartres A; Ravaud P
    PLoS One; 2011; 6(8):e23611. PubMed ID: 21858184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
    Gagne JJ; Polinski JM; Jiang W; Dutcher SK; Xie J; Lii J; Fulchino LA; Kesselheim AS
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug Approval.
    Kesselheim AS; Eddings W; Raj T; Campbell EG; Franklin JM; Ross KM; Fulchino LA; Avorn J; Gagne JJ
    PLoS One; 2016; 11(10):e0163339. PubMed ID: 27768700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and perceptions of final-year Doctor of Pharmacy students about generic medicines in Karachi, Pakistan: a quantitative insight.
    Jamshed SQ; Ibrahim MI; Hassali MA; Sharrad AK; Shafie AA; Babar ZU
    Adv Med Educ Pract; 2015; 6():359-66. PubMed ID: 26028981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis for bioequivalence review.
    Chow SC; Liu J
    J Biopharm Stat; 1997 Mar; 7(1):97-111. PubMed ID: 9056591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of brand or generic labeling on medication effectiveness and side effects.
    Faasse K; Martin LR; Grey A; Gamble G; Petrie KJ
    Health Psychol; 2016 Feb; 35(2):187-90. PubMed ID: 26462056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Power of Labeling in Nocebo Effects.
    Faasse K; Martin LR
    Int Rev Neurobiol; 2018; 139():379-406. PubMed ID: 30146055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey.
    Kesselheim AS; Gagne JJ; Franklin JM; Eddings W; Fulchino LA; Avorn J; Campbell EG
    J Gen Intern Med; 2016 Jun; 31(6):609-14. PubMed ID: 26883524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities.
    Alemayehu C; Mitchell G; Nikles J; Aseffa A; Clavarino A
    BMC Health Serv Res; 2018 Aug; 18(1):624. PubMed ID: 30089496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the intrasubject variation in drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trials.
    Yu Y; Teerenstra S; Neef C; Burger D; Maliepaard M
    Br J Clin Pharmacol; 2016 Apr; 81(4):667-78. PubMed ID: 26574160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
    Kohli E; Buller A
    South Med J; 2013 Feb; 106(2):155-60. PubMed ID: 23380752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.